Atlas Trials

A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

Clinical trial NCT05877053 · COMPLETED

Trial details

NCT number
NCT05877053
Sponsor
Cytokinetics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2023-05-09
Primary completion
2024-11-20
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.